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BACKGROUND:Patients andhealthcare stakeholders are
increasingly becoming engaged in the planning and con-
duct of biomedical research. However, limited research
characterizes this process or its impact.
OBJECTIVE:We aimed to characterize patient and stake-
holder engagement in the 50 Pilot Projects funded by the
Patient-Centered Outcomes Research Institute (PCORI),
and identify early contributions and lessons learned.
DESIGN: A self-report instrument was completed by
researchers between 6 and 12 months following project
initiation.
PARTICIPANTS: Forty-seven principal investigators or their
designees (94 % response rate) participated in the study.
MAIN MEASURES
Self-report of types of stakeholders engaged, stages and
levels of engagement, facilitators and barriers to engage-
ment, lessons learned, and contributions from engage-
ment were measured.
KEYRESULTS:Most (83%) reported engagingmore than
one stakeholder in their project. Among those, the most
commonly reported groups were patients (90 %), clini-
cians (87 %), health system representatives (44 %), care-
givers (41 %), and advocacy organizations (41 %). Stake-
holders were commonly involved in topic solicitation,
question development, study design, and data collection.
Many projects engaged stakeholders in data analysis,
results interpretation, and dissemination. Commonly
reported contributions included changes to project meth-
ods, outcomes or goals; improvement of measurement
tools; and interpretation of qualitative data. Investigators
often identified communication and shared leadership
strategies as Bcritically important^ facilitators (53 and
44 % respectively); lack of stakeholder time was the most
commonly reported challenge (46 %). Most challenges
were only partially resolved. Early lessons learned includ-
ed the importance of continuous and genuine partner-
ships, strategic selection of stakeholders, and accommo-
dation of stakeholders’ practical needs.
CONCLUSIONS: PCORI Pilot Projects investigators report
engaging a variety of stakeholders across many stages of
research, with specific changes to their research attribut-
ed to engagement. This study identifies early lessons and
barriers that should be addressed to facilitate engage-
ment. While this research suggests potential impact of
stakeholder engagement, systematic characterization
and evaluation of engagement at multiple stages of re-
search is needed to build the evidence base.
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INTRODUCTION
Patients and other key healthcare stakeholders are increasingly
becoming engaged in the planning and conduct of biomedical
research.1,2 Patients and stakeholders can be engaged across
stages of research including identifying study topics, choosing
hypotheses, analyzing data, and disseminating findings3–5 (see
Table 1 for illustrative examples). Levels of engagement range
from consultation, to collaboration in bi-directional partner-
ships with researchers, to stakeholder-directed projects.6 Par-
ticipatory research approaches have been increasingly recog-
nized as potentially beneficial in several countries,7–10 and a
robust community-based participatory research literature
documents key issues in including communities in research.11
In the US, growing support for engaged health research is
demonstrated by patient engagement programs at several fed-
eral health agencies.12–15 In 2010, the Patient-Centered Out-
comes Research Institute (PCORI) was established to fund
comparative clinical effectiveness research (CER) to assist
patients, clinicians, and other healthcare stakeholders in mak-
ing informed health decisions.16 PCORI requires research
engagement in all its funded CER studies.17
Despite increased attention to engagement, descriptive in-
formation about engagement in health research is limited.
Some reviews describe engagement in published studies and
report impacts of engagement,1,3,18–21 but the sparse detail on
how engagement is implemented,22,23 and the lack of system-
atic characterization and evaluation of engagement5,24,25 high-
light the need for additional approaches for obtaining infor-
mation on engagement. Some earlier studies describe engage-
ment in research in the U.K.,26,27 but no systematic measures
exist to characterize or evaluate engagement. The literature
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provides insufficient information to permit identification of best
practices and guidelines for replication by others. Researchers
have acknowledged the need for a better understanding of
optimal approaches to engagement, and the opportunity to learn
more about engagement from PCORI’s funded projects.24 This
paper presents our work to collect information about engage-
ment of patients and other stakeholders in PCORI’s first awar-
dees, the 50 PCORI Pilot Projects.
MATERIALS AND METHODS
Sample and Data Collection
In 2012, PCORI awarded contracts totaling $31 million for 50
PCORI Pilot Projects (http://www.pcori.org/assets/PCORI-Pi-
lot-Projects-Funding-Announcement-Amendment-1-_v2_-
09302011.pdf). The intent of this funding was to advance
methods for patient-centered outcomes research. Unlike sub-
sequent PCORI funding, these first projects were intended to
have an explicit focus on methods (analytic methods, outcome
measures, or other specific aspects of research methods).
Projects were funded for a maximum of 2 years and
$250,000 in direct costs. Engagement of patients and other
stakeholders was one criterion by which PCORI evaluated the
proposals for funding (as well as significance, investigators,
innovation, approach, and environment). PCORI required en-
gagement unless the applicant sufficiently explained why
engagement was not pursued.
AcademyHealth, a national health services and policy re-
search organization, was competitively selected to support
active management of the PCORI Pilot Projects. PCORI and
AcademyHealth collected data regarding engagement of
patients and other stakeholders in the design, conduct, and
dissemination of the projects (response was voluntary). MaGil
IRB provided Institutional Review Board (IRB) approval for
secondary analysis of these data.
All 50 PCORI Pilot Project principal investigators (PIs) or
their designees were invited to complete an online question-
naire28 in July 2013 (approximately 6 to 8 months following
project initiation). We sent two reminders 3 and 6 weeks later
and a final personalized reminder in early November.
Measures
The instrument (Appendix A, online) was developed by the
PCORI and AcademyHealth team based on PCORI’s concep-
tual model for patient-centered outcomes research,29 key in-
formant interviews with five Pilot Project PIs, qualitative
analysis of Pilot Project research proposals, discussion with
the PCORI Patient Engagement staff, and literature review, as
noted below. In addition to capturing descriptive elements
(who, when, and extent of engagement), the instrument con-
tent followed the conceptual model categories of ways to
partner, communication, capture and use of perspectives,
and perceived influence of partners. To inform future practice,
the instrument also addressed challenges to and facilitators of
engagement.
Stakeholders Engaged. Respondents reported whether they
had engaged patients or stakeholders in ways other than as
research subjects, the types of stakeholders engaged in their
project, and the number of individuals engaged.
Level of Engagement. Respondents classified the extent to
which each stakeholder type was engaged: 1) Consultation:
researchers use stakeholder views to influence decision-
making regarding research. Consultation allows researchers
to obtain stakeholder views without necessarily being com-
mitted to act on them; 2) Collaboration: stakeholders have an
ongoing partnership with researchers and greater ownership of
the project; or 3) Stakeholder-led: stakeholders initiate, design,
and undertake the research process.6
Table 1. Illustrative Examples from the Peer-Reviewed Literature of Patient and Stakeholder Activity by Research Stage
Stage of the research process Engagement activities in past research
Topic solicitation, agenda setting and development
of research questions
• Provide input on the research topic, prioritization/agenda setting and how
to frame the research question46–48
• Selection of outcomes studied47–49
Proposal development • Provide input on lay/plain language summaries for funding applications48
• Solicit or amass funding50
• Identify and build partnerships with researchers50
• Provide support for IRB approval process50
Methods/study design • Select study design48,49
• Select or develop data collection tools46–48,51
Recruitment • Recommend strategies for more successful recruitment48,50
Data collection • Deliver the research data instrument or conduct participant interviews47,52
• Develop and host biobanks or registries that serve as sources of data50
Data analysis • Participate in coding the data and data analysis47
• Suggest themes for qualitative analysis48
Results review, interpretation, and translation • Interpret research findings51
• Highlight most patient-relevant findings51
• Identify implications of results for health care delivery51,52
Dissemination • Communicate results to other patients, community, and researchers48,51
IRB Institutional Review Board
Examples were selected from a literature scan of engaged research.25 Numbers in parentheses indicate study references
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Nature of Relationships. Respondents reported on the
relationship duration (classified as < 1 year, 1 to 3 years, >
3 years); this provided insight into whether the relationship
was pre-existing or newly established.
Stages of the Research Project. Respondents indicated the
stages of research in which each stakeholder type was
engaged.3,5
Facilitators of and Challenges for Engagement.
Respondents classified a list of possible engagement
facilitators on a four-point Likert scale (BNot at all
important^ to BCritically important^) or Bn/a^ if not used
by their team. Respondents identified challenges to en-
gagement experienced by their team from a list and
rated the extent to which challenges were resolved on
a three-point Likert scale (BNot at all^ to BCompletely^).
We developed these items based on a review of the
literature5,30–36 and knowledge of the investigators’
experiences obtained through interviews and facilitated
group discussions with investigators.
Evaluation of Stakeholder Influence. Respondents indicated
(yes/no) whether they planned to evaluate the influence of
stakeholders on the research project.
Open-Ended Questions.Respondents answered several open-
ended questions about how relationships with stakeholders
were established, challenges to engagement, contributions of
patients and other stakeholders, and initial learnings about
engagement.
Analysis
Descriptive statistical analyses (including frequencies, propor-
tions) were performed using the survey platform.28 The ma-
jority of items were created as closed-ended Likert-scaled
ratings; we examined percent of sample reporting each re-
sponse category and interpreted based on response scale. We
analyzed responses from open-ended questions (motivations
for engagement, establishment of relationships, challenges,
lessons learned, and contributions of stakeholder partners)
using a descriptive qualitative approach, with each question
treated as its own deductive code. Responses to each question
were grouped by sub-codes representing themes identified
inductively by one member of the team (LEE), and reviewed
by another member (LPF). Disagreements were resolved
through consensus.
RESULTS
Researchers from 47 of the 50 projects completed ques-
tionnaires (94 %; 33 PIs and 13 other designated
research staff). These projects were geographically dis-
tributed(Northeast=30 %, South=27 %, Midwest=12 %,
West=30 %). Almost half (46 %) of the projects focused
on four health care decision supports; while 30 % fo-
cused on research prioritization and analytic methods,
15 % were about developing outcomes instruments,
and 13 % related to developing technology and infra-
structure for patient-centered outcomes research.
Engagement of Patients and Other
Stakeholders
Most respondents (83 %, N=39) reported engaging
patients or other stakeholders in their project in ways
other than as research subjects. Among those, investiga-
tors most commonly reported engaging patients/
consumers (90 %), clinicians (87 %), clinic/hospital or
health system representatives (44 %), caregivers/family
members (41 %), or patient or caregiver advocacy
organizations (41 %) (Fig. 1). Most projects (84 %)
engaged at least two types of stakeholder; 22 %
reported engaging four or five types of stakeholders.
The primary motivation for engaging patients, their
caregivers, and advocacy organizations was to under-
stand their values and perspectives on items such as
the impact of a disease, the most appropriate interven-
tions, the importance of specific study outcomes, and
research products that meet patients’ needs. The primary
motivations for engaging clinicians included their Bclinical
and methodological expertise^ and Binsights^ into care
delivery, obtaining clinician Bbuy-in,^ and ensuring that
the research outcomes were clinically meaningful and
translatable.
A notable proportion of relationships between
researchers and stakeholders existed for < 1 year
(37 % of patients, 36 % of caregivers/family members,
19 % of clinicians, 33 % of patient or caregiver
advocacy organizations, 27 % of health system repre-
sentatives). However, some researcher-stakeholder rela-
tionships were more long-standing (> 3 years), partic-
ularly relationships between researchers and clinicians
(50 % of clinicians, 36 % of health system represen-
tatives, 27 % of caregivers/family members, 23 % of
patients, 22 % of patient or caregiver advocacy organ-
izations). Researchers reported establishing new rela-
tionships with patient stakeholders through traditional
recruitment in the clinical care setting (e.g., staff out-
reach, mailings, and flyers); clinician referrals; com-
munity outreach; or utilizing investigators’ existing
networks with colleagues, patients, and advocacy
organizations.
Regarding engagement of patients specifically, 15 %
of projects reported engaging one patient, while 56 % of
projects reported engaging ≥ six patients. Most projects
reported engaging patients as consultants (35 %) or
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collaborators (53 %) rather than as co-leaders (6 %). At
the time of assessment, patients had engaged most com-
monly at the stages of research question development,
proposal development, study design, data collection, top-
ic solicitation, and results review (Fig. 2). Respondents
engaging other stakeholder types gave similar responses
regarding the level of engagement and research stages
(Appendix B, online).
Challenges to and Facilitators for Engagement
The most commonly reported challenges to engagement
were lack of stakeholder time (46 %), lack of research
team time (35 %), lack of stakeholder training/
background (30 %), difficulty in finding the appropriate
representatives to engage (27 %), lack of research team
resources (24 %), and lack of research team training/
background (22 %). Respondents generally described
these challenges as Bpartially resolved,^ and shared
some tangible strategies (Table 2). Respondents also
reported establishing trust and learning how to work
together as challenges. Some solutions to these chal-
lenges included allowing ample opportunity for stake-
holders to ask questions, communicating through mul-
tiple channels, having face-to-face meetings, making
t ime to social ize, and training researchers on
engagement.
Respondents most commonly endorsed communication
strategies and shared leadership approaches as Bcritically
important^ facilitators (49 and 41 %, respectively). Examples
of communication strategies included: trying different
arrangements (big group, small group, individual) to
see what works best; maintaining regular contact with
stakeholders; interacting through multiple channels
(online, teleconference, in-person); using non-technical
language; and holding pre-meetings with stakeholders
Figure 2. Stages of the research project in which patients were engaged (among PCORI pilot project investigators reporting engagement of
patients, n=34).
Figure 1. Types of stakeholders engaged in the PCORI pilot projects (among those projects who reported any engagement, n=39).
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to go over items to be discussed in larger meetings.
Examples of shared leadership strategies included:
adopting a perspective of shared responsibility for
decision-making, training of research team members,
and involving research partners in research team meet-
ings. Respondents also endorsed remuneration, training
of stakeholders, and training of researchers as Bimportant^
(41 %, 38 %, and 30 %, respectively) (Fig. 3).
Early Lessons Learned about Engagement
Early lessons learned (Table 3) suggest the benefits of estab-
lishing meaningful partnerships with stakeholders rather than
engaging stakeholders merely to fulfill a requirement.
Researchers reported the importance of selecting stakeholders
strategically to fit project needs, continuously involving stake-
holders, adapting to the practical needs of stakeholders, and
clearly defining roles and expectations for research partners.
Respondents also emphasized the importance of in-person
contact for relationship building.
Contributions of Patients and Other
Stakeholders
Twenty-one projects (57 %) planned to assess the influence of
stakeholders on the research process. The themes that emerged
regarding early tangible contributions to the research projects
from patients and stakeholders included changes to the project
outcomes or goals, changes to the project methods, enhanced
access to study populations or study settings, modifications to
the study interventions, and refinement of the study instru-
ments or interview questions. Although still in the early stages,
several projects identified contributions of patients and stake-
holders to results interpretation and dissemination of findings
(Table 3).
DISCUSSION
To address the need for more information about engagement in
research, we created and fielded a data collection tool to obtain
information about stakeholder engagement practices and strat-
egies employed in PCORI’s Pilot Projects. In the first 6 to
12 months of these projects, researchers most commonly
engaged patients, and the majority of projects engaged multi-
ple types of stakeholders. Compared to the published litera-
ture, which reflects lesser engagement of other types of stake-
holders,1,18 many PCORI Pilot Projects reported engaging
clinicians (> 85 %), and a substantial number of projects
reported engaging with caregivers, advocacy organizations,
and health system representatives (>40 % for each). However,
similar to previous studies, few investigators reported engag-
ing purchasers, payers, policy makers, and the life sciences
industry. This pattern may reflect the basic methods research
focus of the funding; the stakeholders engaged by these awar-
dees are those most proximal to the methods questions
addressed. Subsequent PCORI funding that has a focus on
comparative effectiveness research rather than methods re-
search is expected to expand the universe of stakeholders
engaged. Our findings highlight the need for a better under-
standing of how the views frommultiple types of stakeholders
are incorporated into a study and of the impact of relationship
length and quality on the research process. While engagement
was most frequently reported in developing research ques-
tions, consistent with other reports,1,37 the extent of engage-
ment in data collection, data analysis, interpretation of results,
and dissemination is noteworthy. Engagement in these
later phases is expected to increase as projects progress.
While the challenges, facilitators, and lessons learned
reported here are generally consistent with the existing
literature,3,5,19,20,38–40 this study is unique in capturing
this information systematically and assessing the relative
Table 2. Challenges to Engaging Patients and Other Stakeholders in Research Reported by PCORI Pilot Projects Investigators (N=37)
Resolved
Challenge % Not at all % Partially % Completely % Strategies for resolution
Lack of stakeholder time 46 6 65 29 • Surveying stakeholders and planning
meetings with significant lead time
• Hold meetings less frequently or with
fewer stakeholders
• Provide maximum compensation
Lack of research team time 35 8 77 15 NR
Lack of stakeholder training/background 30 0 73 27 • Seeking out support from existing
resources
at their institution
Difficulty finding appropriate representatives
to engage
27 10 70 20 • Expand their stakeholder recruitment by
networking within the group of stakeholders
already engaged
Lack of research team resources 24 0 78 22 NR
Lack of research team training/background 22 0 63 38 • Researcher training on cultural sensitivity
and community engagement
Lack of stakeholder resources 16 17 83 0 NR
Lack of perceived value among stakeholders 11 25 75 0 NR
Lack of perceived value among research
team
8 0 100 0 NR
NR none reported
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importance across a group of projects. Our findings collectively
highlight the effort, attention, resources, and flexibility required
for concerted engagement. Across these survey responses, for
example, respondents emphasized meaningful and continuous
partnerships, shared leadership strategies, communication
through multiple strategies that fit specific stakeholder partners,
and adaptation to the practical needs of stakeholders. Similarly,
others highlighted the importance of sharing power for success-
ful research engagement.41 Lack of time—both for stakeholders
and researchers—was the most frequently noted challenge and
was identified as a top barrier to engagement in a recent survey
of patients and clinicians.39 Thus, it is critical to recognize
resource needs and develop strategies that maximize stakehold-
er input while minimizing the time burden, and the responses
provide support for elements in the conceptual model that
helped to inform these items.29
Most challenges experienced were only partially resolved.
Challenges to engagement remain to be addressed in terms of
individual research team process as well as through institu-
tional and funding agency infrastructure. Some issues have
tangible solutions (e.g., financial support of partnership in
research budgets, matching researchers with stakeholder part-
ners); others require change in social norms (e.g., developing
meaningful partnerships). PCORI supports several efforts to
address these issues, including funding opportunities for de-
veloping research partnerships (http://www.pcori.org/funding-
opportunities/pipeline-to-proposal-awards/) and for develop-
ing training and building capacity for engagement (http://
www.pcori.org/funding-opportunities/eugene-washington-
pcori-engagement-awards/).
This study also demonstrates the contributions that engaged
stakeholders had already made in the first year of the projects.
Researchers reported that patient and stakeholder input
resulted in changes to study outcomes, goals, methods, inter-
ventions, and materials. These contributions may enhance the
appropriateness of study materials,19,21 and the relevance of
the research questions and outcomes1,3,18,21,22,42–44 to the
study population. Some projects reported stakeholder contri-
butions to the interpretation of qualitative data, which may
help researchers to contextualize findings for specific audien-
ces.3,21 Increased access to study populations or settings sug-
gests that engagement may mitigate commonly encountered
challenges with recruitment and retention.3,18,22,43 These
results are consistent with available evidence on positive
impacts of engaged research on research process and dissem-
ination of results.1,6,18,21,22,42–45 More research is needed to
better understand how engagement impacts research quality,
relevance, and dissemination.
While the findings represent significant progress towards
systematically understanding engagement in research, several
limitations should be considered. We obtained only research-
ers’ perspectives, which may differ from the views of other
stakeholders engaged.26 This tool did not assess principles of
engaged research (e.g., trust, respect) that have been identified
as important to the success of engagement. While others have
noted important negative impacts of engagement,21 the current
tool did not specifically ask about these effects and thus did
not provide new insights on drawbacks. Obtaining informa-
tion at later stages of research projects will permit evaluation
of engagement outcomes.
Figure 3. Facilitators of engaging patients and other stakeholders in research (among PCORI pilot projects reporting any engagement, n=36).
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Additional information about construct validity of the mea-
sure is needed. Results obtained here should be compared to
other forms of project reporting, including open-ended project
status updates required of awardees and conversations between
funding agency staff and awardees. Future data collection
efforts should include appropriately timed repetition of key
items. Additionally, further cognitive testing of items is war-
ranted to ensure item intent is understood by respondents and
that responses reflect respondent intent.
The generalizability of these findings may be limited be-
cause respondents were investigators on methods projects
rather than health outcomes or CER. Because these respond-
ents were the first PCORI awardees, they also may have more
interest in and experience with engagement than the broader
health research community. Thus, their knowledge and
attitudes about engagement may be more positive. Finally,
these self-report data may overestimate research engagement,
particularly given the role of the research funder in data
collection. Many of these limitations will be addressed in
future data collection efforts with PCORI awardees.
Engagement in research is becoming more widespread as the
value of end-user needs and perspectives is recognized, and as
funding initiatives requiring or encouraging engagement prolif-
erate. Since the PCORI Pilot Projects were funded, researchers
have become more familiar with the concept of research engage-
ment. PCORI has provided additional guidance to applicants
regarding its funding requirements related to engagement in
research and is continuing to collect information on engagement
from PIs and their patient and stakeholder partners to inform the
literature and PCORI’s policies regarding research engagement.
Table 3. Summary of Main Themes Identified from Responses to Select Open-Ended Questions
Early Lessons Learned
BBased on your interactions with all of these stakeholders up to this point, what initial learnings can you offer to others regarding engaging patients and
other stakeholders in research?^ (N=35)
Theme 1: Seek genuine partnership Respondents emphasized that partnerships with stakeholders must be genuine. For example, one
respondent commented, Btheir participation was enhanced because they quickly realized that their role
was not symbolic in nature but was integral to the project’s development in many ways.^ Respondents
sought to actively involve stakeholders in the decision-making process, which contributed to shared
ownership of the project.
Theme 2: Select stakeholders strategically Respondents recognized the need to strategically select stakeholders representing a variety of different
communities or viewpoints and the need to identify the necessary viewpoints to match project specific
goals. For example, one respondent described their work as follows: BThe three types of stakeholders
are quite different and all have been essential to the project. We would not have written a proposal
without the administrative stakeholders, the patients and providers are describing the issue of
behavioral health within the clinic and identifying their preferences in patient-centered care, and the
stakeholder group is deciding how they can feasibly change the way they administer services to meet
these needs.^
Theme 3: Continuously involve
stakeholders
Respondents acknowledged the need to Bstart early^ and Bask often^ as patient and other stakeholders
have unique knowledge and improvements to add to the research process along the entire research
continuum.
Theme 4: Adapt to the practical needs of
stakeholders
Respondents noted the benefits of addressing the practical needs of stakeholders to facilitate their
participation (e.g., scheduling meetings outside of traditional working hours, providing transportation).
Theme 5: Define expectations and roles Respondents identified establishing Bparameters and expectations for roles^, giving stakeholders
guidance, and allowing time for stakeholders to Bget comfortable with their roles^ as important tasks.
Theme 6: Use in-person contact to build
relationships
To establish strong working relationships, respondents recommended having multiple meetings and
underscored the importance of face-to-face contact. While technology and electronic interfaces were
noted as facilitators of collaborations across distances, several respondents highlighted the importance
of laying the foundation for partnerships through initial in-person meetings.
Contributions of Patients and Other Stakeholders
BUp to this point, what are the most significant contribution(s) made by these patients and other stakeholders?^ (N=36)
Theme 1: Changes to project outcomes or
goals
Researchers reported that engagement of patients and stakeholders led to a shift in the outcomes of
interest to the project. As one respondent described, engaging patients helped the team realize that
researchers’ priorities Bdo not always match priorities of patients.^ Another respondent noted BI can
say with confidence that our project (the methods and even the project goals) have evolved, in some
cases dramatically, based on our collaborations with stakeholders.^
Theme 2: Changes to project methods Respondents indicated that input through engagement affected their methods in a variety of ways. As
one respondent noted, Bpatient/family collaborators' input was absolutely essential to developing our
methods.^ For example, patients and stakeholders helped researchers Bdevelop appropriate plans and
processes for recruiting patients and interviewing them.^ They also helped to improve the ease of data
collection, which the respondent indicated may help to speed data collection.
Theme 3: Enhanced access to populations
or study settings
Respondents reported that stakeholders facilitated access to clinical professionals and clinical settings
in which studies can be conducted.
Theme 4: Modifications to interventions Stakeholders’ feedback was said to have influenced the development of study interventions, for
example, by increasing their ease of use or the manner in which they were implemented.
Theme 5: Refinement of instruments and
interview questions
Input into instrument development included pilot testing study instruments, giving Bstrategic advice^
about the length of surveys, and ensuring that the right questions are included for both quantitative and
qualitative methods of data collection. As one respondent noted, Bour patient collaborators have
fundamentally changed the way we ask important questions of patients and families.^
Theme 6: Interpretation and dissemination
of results
While most projects were still in the early stages, contributions of patients and stakeholders for
interpreting and disseminating results were beginning to emerge. Respondents identified meaningful
patient and stakeholder contributions to the interpretation of qualitative findings. One respondent also
noted, Bthey have also changed the way we share study results with kids and families. I mean, they
have SERIOUSLY changed things.^ Multiple respondents indicated that they expect to engage
stakeholders in the interpretation and dissemination of results once findings are available.
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The evidence on engagement will grow if researchers sys-
tematically document more information about engagement
and its impact on individual projects in publications,1,23 if
relevant medical subject headings (MESH) indexing terms
for patient engagement are developed,3 and if information on
engagement is systematically collected from researchers and
research partners. PCORI continues to collect and use learn-
ings from engagement in funded projects. Future research
should evaluate the impact of engagement at each stage of
the research process, including the effects of engagement in
interpretation of results and dissemination on the clinical
uptake of findings. Studies should consider both positive
impacts and potential undesirable consequences of engage-
ment, and strategies for mitigating unintended consequences.
Furthermore, future evaluations should identify which strate-
gies for engagement—which stakeholders to involve, how to
involve them, and at what stages of process—have the greatest
positive impact on research quality and usefulness to patients and
their caregivers and other end users of the research. Ultimately,
evaluations demonstrating links between engagement and
longer-term outcomes such as health decision making and health
outcomes29 are needed to develop evidence-based guidance
about the best approaches to engagement in research.
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